[1]
“A Comparison of Intravenous Esmolol versus Intravenous Diltiazem in Atrial Fibrillation with Rapid Ventricular Response-A Study from An Academic Center”, ccm, vol. 4, no. 4, pp. 450–459, Aug. 2020, Accessed: Sep. 18, 2026. Available: https://fortunejournals.org/ojs/index.php/ccm/article/view/15908